news2024-09-14T14:30:42+00:00#ESMO24: Incyte gears up to face FDA once again with more Zynyz data in rare anal cancer
news2024-09-14T12:45:18+00:00#ESMO24: Pfizer tees up Phase 3 in 2025 in weight management, but in an unexpected area
news2024-09-14T11:57:03+00:00#ESMO24: Bristol Myers touts LAG-3 strategy in lung cancer as it preps for showdown with Merck’s Keytruda
